Bevacizumab improved prognosis for advanced EGFR-mutant lung adenocarcinoma with brain metastasis receiving cerebral radiotherapy

CONCLUSION: In patients with BM from EGFR-mutated NSCLC, cerebral radiotherapy with bevacizumab markedly improved OS. This improvement was more evident after cerebral radiotherapy.PMID:38478262 | DOI:10.1007/s12094-024-03418-3

Source: Clinical Lung Cancer - March 13, 2024 Category: Cancer & Oncology Authors: Yuanliang Zhou Jingchao Li Yankang Li Guangchuan Deng Qi Wang Hongyue Qin Jianbin Li Zhenxiang Li Source Type: research